Drug Pricing Archives - Inbeeo Strategic Market Access & Pricing

Home
What we do

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

What we do

Define your value strategy

We offer best-in-class strategy development tailored to your objectives to help realize the full value of your products and technologies.

Optimize your evidence plan

We can help you collect and understand complex data about your asset, indications, and the pricing and access environment, then turn them into simple overviews and strategic insights with impact.

Price your asset right

Our pricing solutions help you achieve a price for your health technology which reflects its true value to patients, different healthcare systems and society as a whole.

Communicate the value

We work with you to gather the evidence, formulate the insights, and create the arguments you need to explain the value of your technology to payers and other key healthcare stakeholders.

Navigate access policies

We help our customers align their internal priorities with external health policy developments to bolster overall success.
Who we are

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Who we are

Our Team

Our team represents a unique combination of expertise gained at leading pharmaceutical companies, leading consultancies, and leading universities.
Our Products

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Our Products

i•vbp

Easy-to-use and secure cloud-based application that enables the generation of custom value frameworks tailored to demonstrate the full value of your assets.

i•pec

We have a strong network of international payers and experts with decades of experience in HTA, P&R and HEOR in their local markets.

i•las

Bringing together global market access leaders for collaborative discussions on industry-wide topics and challenges.
Our Insights

Latest Article

Equity Pricing in the Real World: Moving from Ambiguity to Action for Patients, Payers, and Health Systems

Aligning equitable access and commercial sustainability is one of the
Read More »

Our Insights

Perspectives

A deep dive into the world of Market Access. Discover our perspectives on the latest developments in our field.

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

News

Find out what’s going on with Inbeeo, where we’ve been and who we’ve been talking to.
Join our team

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

US - EU Price Differences

Navigate access policies

How IRA Negotiations Are Shaping US-EU Drug Price Differentials

Four Market Access Measures Triggered By COVID-19 That Are Here To Stay

Navigate access policies

Four Market Access Measures Triggered by COVID-19 That Are Here To Stay

Drug R&D Public Funding - The Next Level Of Price Transparency Policies

Drug Pricing

Drug R&D Public Funding – The Next Level Of Price Transparency Policies?

Estimated Annual Cost Saving Across Medicare for Five Drugs Which Cause Significant Costs to the US Healthcare System

Price Your Asset Right

Tackling Rising Drug Costs in the US: Is ERP an Option?

Price Your Asset Right

4 Take-Away Messages From The Zolgensma® Pricing Storm

Data Analysis

Decoding the data: Analytics of Drug Pricing Tweets

What is Value Based Pricing?

Drug Pricing

Four Definitions of Value-Based Pricing and Counting

The Six Drugs that on Average Cost Patients over $10,000 a Year

Drug Pricing

Six Drugs that Cost a Medicare Part D Beneficiary more than $10,000 a Year

Google Search Index for drug pricing and Martin Shkreli over the past 5 years

Data Analysis

The Dust Never Settled after Drug Pricing 9/22

Drug Pricing

Why I Prefer a Value-Based Healthcare Mayhem over the Status Quo